Biotech China 2014

Stem Cells: Abbott Laboratories

Total Score People Score Events Score
11 8 9
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Stephen Fesik
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Rod Humerickhouse
March 19, 2013 REGEN 2013: Clinical Trials & Reimbursement Baxter Phase III Program in Refractory Angina and Chronis Myocardial Ischemia Adel Nada
March 19, 2013 Stem Cells for Drug Developers Chair’s Opening Remarks Gary A. Gintant
Validating Stem Cell-Based Assays and Models for Drug Safety and Discovery Gary A. Gintant
December 2, 2008 2nd Annual Lead Discovery Summit 2008:--Primary & Secondary Screening Virtual screening: How predictive is it of compound success in wet screening campaigns? Steve Muchmore,
March 25, 2008 Mastering Medicinal Chemistry Meeting the Challenges of Our Industry - The Role of Technology in a Winning R&D Strategy James B Summers
Medicinal Chemistry Efforts Leading to the Optimization of Histamine H3 Receptor Antagonists Robert J Altenbach
March 25, 2008 PATHWAY ANALYSIS Integration of Novel Technologies in Discovery and Early Development Toxicology Eric A Blomme
March 25, 2008 Preclinical Development Chairperson’s Remarks Eric A Blomme
Integration of Novel Technologies in Discovery and Early Development Toxicology Development Toxicology Eric A Blomme
March 25, 2008 CANCER MOLECULAR MARKERS Chairperson’s Remarks Eric A Blomme
Integration of Novel Technologies in Discovery and Early Development Toxicology Eric A Blomme
March 25, 2008 TRENDS IN DRUG SAFETY Integration of Novel Technologies in Discovery and Early Development Toxicology Eric A Blomme
Chairperson’s Remarks Eric A Blomme
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.